Zacks Investment Research on MSN

Down 22.6% in 4 Weeks, Here's Why You Should You Buy the Dip in AxoGen (AXGN)

AxoGen (AXGN) has been beaten down lately with too much selling pressure. While the stock has lost 22.6% over the past four ...
Zacks.com on MSN

Down 25% in 4 Weeks, Here's Why You Should You Buy the Dip in Innate Pharma (IPHA)

Innate Pharma S.A. Sponsored ADR (IPHA) has been beaten down lately with too much selling pressure. While the stock has lost ...
Zacks Investment Research on MSN

AptarGroup (ATR) loses 5.9% in 4 weeks, here's why a trend reversal may be around the corner

AptarGroup (ATR) has been on a downward spiral lately with significant selling pressure. After declining 5.9% over the past ...
Seeking Alpha

RSI (Relative Strength Index): Timing The Next Correction

In the world of technical analysis, there is one reliable indicator for measuring market risk. The relative strength index measures overextension. Investors commonly use a lookback period of 14 days ...

Down 9.4% in 4 Weeks, Here's Why Western Midstream (WES) Looks Ripe for a Turnaround

Western Midstream (WES) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings ...